Stay updated on Quizartinib Plus FLAG-IDA in AML Clinical Trial

Sign up to get notified when there's something new on the Quizartinib Plus FLAG-IDA in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Quizartinib Plus FLAG-IDA in AML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer/site revision label updates from “v3.5.2” to “v3.5.3,” reflecting a ClinicalTrials.gov platform/version change and not a change to the trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:40:19.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    New revision v3.5.2 added and previous revision v3.5.0 removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:12:36.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was deleted in the Record History.
    Difference
    0.1%
    Check dated 2026-03-18T20:17:21.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The record history now includes the new revision v3.4.3 and shows the removal of revision v3.4.2, reflecting an update to the study record.
    Difference
    0.1%
    Check dated 2026-03-11T17:17:32.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 was added to the history. The government funding notice and the earlier Revision: v3.4.1 entry were removed.
    Difference
    0.8%
    Check dated 2026-02-11T05:25:33.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    A site-wide operational notice about funding and status was added, and the revision tag now shows version 3.4.1 (replacing 3.4.0).
    Difference
    0.8%
    Check dated 2026-02-04T05:22:14.000Z thumbnail image

Stay in the know with updates to Quizartinib Plus FLAG-IDA in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Quizartinib Plus FLAG-IDA in AML Clinical Trial page.